ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

Tough Year Seen for Cooperative Groups; Priority Payment Questioned

December 2, 1988

In Brief: Robert Weinberg to Receive Bristol-Myers Award; Leffall Chosen for Poster Series

April 13, 1984

20% of Women Do Not Believe Tailored Risk Assessments

August 30, 2013

NCI Reportedly Gets $691 Million From House, Senate Conferees

October 4, 1974

FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”

January 7, 1977